Cytek Biosciences, Inc. financial data

Symbol
CTKB on Nasdaq
Location
Fremont, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 545 % -20.4%
Quick Ratio 67.1 % -28.4%
Debt-to-equity 28.7 % +11.4%
Operating Margin -11.8 % +90.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 128M shares -0.73%
Common Stock, Shares, Outstanding 128M shares -1.47%
Entity Public Float 670M USD -35%
Common Stock, Value, Issued 128K USD -1.54%
Weighted Average Number of Shares Outstanding, Basic 128M shares -2.64%
Weighted Average Number of Shares Outstanding, Diluted 128M shares -3.94%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 201M USD +813%
Revenue from Contract with Customer, Excluding Assessed Tax 197M USD -2.18%
Research and Development Expense 37.2M USD -8.19%
Selling and Marketing Expense 48.2M USD -1.26%
General and Administrative Expense 51.6M USD +15.2%
Operating Income (Loss) -31.8M USD -34.5%
Nonoperating Income (Expense) 16.3M USD +39.1%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -15.5M USD -30%
Income Tax Expense (Benefit) -2.67M USD -52.2%
Net Income (Loss) Attributable to Parent -11.4M USD -84.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 93.3M USD -42.5%
Accounts Receivable, after Allowance for Credit Loss, Current 56.6M USD +7.6%
Inventory, Net 51.6M USD +10.4%
Other Assets, Current 2.92M USD +24.6%
Assets, Current 388M USD -0.44%
Property, Plant and Equipment, Net 18M USD -2.5%
Operating Lease, Right-of-Use Asset 11.2M USD +10.2%
Intangible Assets, Net (Excluding Goodwill) 17.7M USD -13.7%
Goodwill 16.7M USD +3.18%
Other Assets, Noncurrent 4.46M USD -9.92%
Assets 495M USD +0.75%
Accrued Liabilities, Current 20.2M USD -2.41%
Contract with Customer, Liability, Current 28.7M USD -28.4%
Liabilities, Current 75.2M USD +19.8%
Contract with Customer, Liability, Noncurrent 16.3M USD
Operating Lease, Liability, Noncurrent 13.5M USD +74%
Other Liabilities, Noncurrent 2.52M USD +18.8%
Liabilities 116M USD +10%
Accumulated Other Comprehensive Income (Loss), Net of Tax 821K USD +713%
Retained Earnings (Accumulated Deficit) -57.7M USD -28.6%
Stockholders' Equity Attributable to Parent 379M USD -1.79%
Liabilities and Equity 495M USD +0.75%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -125K USD -103%
Net Cash Provided by (Used in) Financing Activities -11.5M USD -816%
Net Cash Provided by (Used in) Investing Activities 9.45M USD
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 128M shares -1.47%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.45M USD -328%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 93.3M USD -42.5%
Deferred Tax Assets, Valuation Allowance 2.8M USD +23.5%
Deferred Tax Assets, Gross 38.8M USD +7.75%
Operating Lease, Liability 16.6M USD +47%
Depreciation 3.8M USD +11.8%
Payments to Acquire Property, Plant, and Equipment 849K USD +49.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.1M USD -42.7%
Lessee, Operating Lease, Liability, to be Paid 21M USD +77.8%
Property, Plant and Equipment, Gross 29.7M USD +11.8%
Operating Lease, Liability, Current 3.09M USD -12.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.63M USD +45.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.37M USD -8.01%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure +32.3%
Deferred Income Tax Expense (Benefit) -336K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.36M USD +771%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.2M USD +38.2%
Deferred Tax Assets, Operating Loss Carryforwards 1.61M USD +13.9%
Unrecognized Tax Benefits 3.6M USD -0.99%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.54M USD -25%
Additional Paid in Capital 435M USD +1.21%
Amortization of Intangible Assets 3.7M USD +5.71%
Depreciation, Depletion and Amortization 1.88M USD +10.4%
Deferred Tax Assets, Net of Valuation Allowance 36M USD +6.69%
Share-based Payment Arrangement, Expense 26.1M USD +2.15%
Interest Expense 1.84M USD -30.8%